McCarthy S, Wilton L, Murray M, et al (2012). The epidemiology of pharmacological treatments for attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.

Mumbai: Lupin Limited announced on Tuesday that it has received approval from the United States Food and Drug Administration ...

Enhanced Cognitive Performance: Vyvamind is designed to serve as a potent neurostimulant, utilizing a precise blend of ...

Elite received approval from the Food and Drug Administration for a generic version of Vyvanse (lisdexamfetamine dimesylate) capsules in strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg ...

However, caffeine shouldn't be considered a treatment for ADHD and it should be used with care. Too much can cause unwanted ...

Attention-Deficit Hyperactivity Disorder (ADHD) is one of the most common mental health disorders ...

ADHD symptoms in school-aged children: School-aged children with ADHD may have symptoms like careless mistakes on school work ...

Some might roll their eyes about yet another trending health label attached to a condition that is slippery to define. Yet ...

NYU Grossman School of Medicine offers a 12-month postdoctoral fellowship within the organizational skills training and ...

The culprit? She says symptoms of common mental health issues like depression, attention deficit hyperactivity disorder (ADHD ...

In May 2024, Knight entered into an agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Ironshore Therapeutics, Inc. (now part of Collegium Pharmaceutical, Inc.; ...